Ruben Villa is demonstrating one loss does not define a career. He has demonstrated he can defeat world titleholders as well. Villa, rated No. 10 by The Ring at 126 pounds, is ready to again fight for a world title belt, but must first get…
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fastly, Inc. (NYSE:FSLY) between February 15, 2024 and May 1, 2024, both dates inclusive (the "Class Period"), of the important July 23, 2024 lead…
A serial killer profiler has revealed the four steps women should take to protect themselves from an attack. Dr Ann Burgess worked with the FBI to create profiles for people suspected of murder.
The class action concerns whether Maxeon and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
The class action concerns whether Toyota and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
The class action concerns whether Nike and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
The class action concerns whether UiPath and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
The class action concerns whether 2U and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
The class action concerns whether Fat Brands and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
The class action concerns whether Lamb Weston and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
The class action concerns whether Roblox and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On June 26, 2024, FDA issued a new draft guidance on clinical trial diversity, “Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies” (Draft Guidance), to assist medical product…
If you are a shareholder who purchased or otherwise acquired SeaStar securities during the Class Period, you have until September 6, 2024 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be…
If you are a shareholder who purchased or otherwise acquired Bolt securities during the Class Period, you have until September 3, 2024 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained…
If you are a shareholder who purchased, or otherwise acquired, Direct Digital common stock during the Class Period, you have until July 22, 2024 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can…